G Medical Innovations Holdings Limited - Warrants (30/06/2025) OverviewTrack G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s EBIT ($-2.7M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2022
Trailing 12 months ending Jun 30, 2022
The latest EBIT for GMVDW is $-2.7M as of June 2022. That compares with $-12M in the prior-year period — up 76.4% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, GMVDW's EBIT moved from $-12M to $-2.7M — a 76.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s operating scale or balance-sheet position.
Against Healthcare companies, GMVDW currently prints $-2.7M for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s growth, margins, and balance sheet.
A EBIT figure of $-2.7M for GMVDW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.
After noting GMVDW's EBIT ($-2.7M), review year-over-year change from $-12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
